James Roose

Articles by James Roose

42 Exploring the Treatment Gap in High-Risk HR+, HER2– Early Breast Cancer: Eligible Patients Not Receiving Abemaciclib in the US

ByAna Sandoval,Joyce A. O’Shaughnessy,Astra M. Liepa,Brenda Grimes,Katheryn Moreira,James Roose,Catherine Keane,Sara M. Tolaney, MD, MPH

May 29th 2025

Latest Updated Articles

Trending on CancerNetwork

Which Lung Cancer Presentations Will Move the Needle at WCLC 2026?

Neoadjuvant Atezolizumab Does Not Significantly Improve EFS in Early TNBC

What Needs to Happen Before Menin Inhibitors Move Into Frontline AML Combinations?

Novel Myelofibrosis Drug is “Versatile” for Managing Anemia

Early Camizestrant Is Favored Upon ESR1 Mutation Emergence in Breast Cancer